GSK-710

N/A

Report date: 2025/03/20 17:26:10
NME

Base Information

Drug NameGSK-710
Drug Alias NameGSK-710GSK710
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A